Leveraging AI in clinical trials critical to the advancement of pharmaceuticals

COVID-19 has radically altered the clinical trial landscape in Australia.

Prior to the pandemic, there was significant potential to roll out a significant number of projects at one time. In fact, in 2019 there were over 1800 ongoing trials taking place within Australia.1 Public attitude regarding willingness to participate in clinical trials comes down to Australia’s sophisticated healthcare system and the skilled workers in the country...